CAT No: CP26187
CAS No:1095952-22-9
Synonyms/Alias:1095952-22-9;Fmoc-Gly-Ser(Psi(Me,Me)Pro)-OH;Fmoc-Gly-Ser(Psime,Mepro)-OH;FMOC-GLU(OTBU)-THR(PSI-ME,MEPRO)-OH;(4S)-3-[2-(9H-fluoren-9-ylmethoxycarbonylamino)acetyl]-2,2-dimethyl-1,3-oxazolidine-4-carboxylic acid;(S)-3-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)acetyl)-2,2-dimethyloxazolidine-4-carboxylic acid;MFCD18427718;(4S)-3-[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)acetyl]-2,2-dimethyl-1,3-oxazolidine-4-carboxylic acid;HY-P2405;Fmoc-Gly-Ser(Psi(Me ,Me)pro)-OH;Fmoc-Gly-L-Ser(Psi(Me,Me)pro)-OH;AKOS025289337;(S)-3-(N-(9-Fluorenylmethyloxycarbonyl)-glycinyl)-2,2-dimethyloxazolidine-4-carboxylic acid;AS-62172;DA-63525;FF111383;CS-0133747;E70866;(4S)-3-{N-[(9H-Fluoren-9-ylmethoxy)carbonyl]glycyl}-2,2-dimethyl-1,3-oxazolidine-4-carboxylic acid;
4. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
5. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.